Marvell Agrees to Acquire Lumentum in $115 Billion All-Stock AI Data-Center Deal

Marvell Technology has agreed to acquire optical-components maker Lumentum Holdings in an all-stock transaction valued at $115 billion, with the deal announced on November 2, 2026, according to CNBC. The combination pairs Marvell's custom AI chip and networking business with Lumentum's optical hardware, which moves data at high speed inside AI data centers, as the chipmaker steps up its rivalry with larger competitor Broadcom amid the broader AI spending boom.

A post on X from the account TheValueist, citing the companies' announcement, described the transaction as an all-stock deal with Lumentum stockholders set to receive a fixed exchange ratio of 4.500 Marvell shares. The same post noted Lumentum traded around $835 in premarket activity, below the $1,009 level that Mizuho had mapped out for even a 20% premium scenario, though neither figure has been independently confirmed by Marvell or Lumentum in the evidence reviewed here.

Why Marvell Is Buying Lumentum

According to CNBC, Marvell is betting that Big Tech's AI spending boom will persist and keep demand for optical components outstripping supply, even though Lumentum is roughly half Marvell's size. That bet is underscored by comments from Lumentum CEO Michael Hurlston, reported by Bloomberg and relayed by Yahoo Finance, that the company's optical components are sold out through early 2029 and that Lumentum cannot meet an estimated 70% of demand for certain products next year despite a planned $350 million investment in Japan.

Nvidia has a direct stake in both sides of the deal. CNBC reported that the AI chip giant invested $2 billion each in Marvell and Lumentum earlier this year, and Hoodline, citing an Nvidia announcement, reported that Lumentum holds a nonexclusive agreement with Nvidia that includes a multibillion-dollar purchase commitment and future capacity access rights for advanced laser components. CNBC also reported that Lumentum, which competes with U.S.-listed Coherent and China's Zhongji Innolight, stands to benefit from a proposed U.S. ban on new Chinese optical transceivers that could shift demand toward domestic suppliers.

Strategic Case and Regulatory Risk

Stifel analyst Tore Svanberg, cited by Yahoo Finance, argued that controlling both silicon and optics could let a combined Marvell-Lumentum codesign system-level performance, power and latency across switching, XPU Attach, DSPs, analog, silicon photonics and InP lasers under one roof, something few suppliers currently span. Svanberg also said the deal could serve as a hedge against geopolitical risk, positioning Marvell as a domestic optics powerhouse if U.S. restrictions hit Chinese optical transceiver vendors that currently supply an estimated 70% of the market, per Yahoo Finance's reporting of his comments.

Svanberg cautioned, however, that actual closing would likely take time to clear both U.S. and Chinese regulatory approval bodies, and flagged a risk of friction with merchant DSP customers who might turn to rival silicon suppliers once Marvell owns a competing optics business, according to Yahoo Finance. No specific closing date or jurisdiction-by-jurisdiction timeline beyond that general caution appears in the reporting reviewed here.

Raymond James analyst Simon Leopold offered a more skeptical read, per Yahoo Finance. Noting Marvell's roughly $4 billion in cash against $5 billion in long-term debt, Leopold said scenarios suggest a combination could be EPS neutral by calendar year 2028 or dilute Marvell's earnings per share by 10% or more, depending on the deal's size and structure — a point he said casts some doubt on the transaction's likelihood. That range is Leopold's own scenario analysis of a potential combination rather than a confirmed outcome.

How the Shares Have Moved

Market reaction has been choppy across the weeks leading up to the formal announcement. Yahoo Finance, citing Investing.com, reported that Lumentum shares surged more than 6% in premarket trading when Bloomberg first reported Marvell was in advanced talks to acquire the company. But CNBC reported that since those talks were first disclosed in late October, Lumentum's shares have fallen about 8% and Marvell's about 22%, as a broad-based chip selloff accelerated following Intel's weak forecast. Yahoo Finance also reported that Alphabet's third-quarter earnings revealed a $9.07 billion free-cash-flow burn, which it said sparked sector-wide anxiety among custom silicon suppliers and compounded Marvell's stock decline. Hoodline, citing Reuters, reported that Marvell had about $3.92 billion in cash and cash equivalents as of its latest quarter, a figure dwarfed by the reported deal valuation, which it said is one reason the transaction was expected to be structured as all stock rather than cash.

Context: A Bigger Bet on AI Infrastructure

The Lumentum deal is Marvell's largest purchase since its $10 billion buyout of Inphi in 2021, according to CNBC, and follows the company's $3.5 billion acquisition of photonics firm Celestial AI, which closed in February as rising use of AI agents and chatbots drove demand for faster optical links connecting thousands of chips in AI data centers. CNBC also reported that Marvell's market value has surged to more than $170 billion, helped by its role supplying custom AI chips and networking technology to tech giants such as Amazon, and that the company's annual revenue has more than doubled from $3 billion in fiscal 2021 to $8.2 billion in fiscal 2026. In August, Marvell signed a chip-supply deal with Google worth up to $120 billion in sales through fiscal 2033, which gave Google the right to buy a $12.2 billion stake in Marvell, CNBC reported.

Bottom Line

Marvell's agreement to acquire Lumentum in an all-stock deal valued at $115 billion is a direct wager that optical bottlenecks in AI data centers will persist, backed by CEO Michael Hurlston's statement, reported by Bloomberg, that Lumentum's optical components are sold out through early 2029. Analysts are split on execution: Stifel's Tore Svanberg sees a genuine codesign and geopolitical advantage, while Raymond James' Simon Leopold flags balance-sheet strain and possible EPS dilution that could cloud the deal's path. With shares of both companies swinging sharply since talks first surfaced, and with Svanberg expecting review by both U.S. and Chinese regulators to take time, the gap between the strategic logic and the financial and regulatory execution risk is likely to remain the central question as the deal moves toward completion.